Document is current

Any future updates will be listed below

Response to: Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM

Crossref DOI link: https://doi.org/10.1007/s12325-022-02328-6

Published Online: 2022-10-19

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark